About IQuity

About IQuity

IQuity, Inc. is a data science company using genomic and proprietary healthcare datasets to detect and monitor chronic disease. At IQuity, we developed a game-changing blood test using RNA data (genomic) to accurately identify autoimmune disease earlier than current, conventional testing methodologies. The application of data science and machine learning is the core of our business and drives our technological development.

IQuity offers three blood tests to help providers diagnose multiple sclerosis, IBS/IBD-Crohn’s and ulcerative colitis, and fibromyalgia with greater than 90 percent accuracy. Disease activity and monitoring tests are currently in development with planned releases in 2018.

MISSION

IQuity’s mission is to relentlessly pursue innovation in specialized diagnostic and analytic technology to identify complicated autoimmune and autoimmune-related diseases at the earliest signs of disease.

  • Enable providers to diagnose early and treat sooner in the disease progression
  • Lower the overall cost of life-long autoimmune disease
  • Minimize patient uncertainty and fear, which is often associated with traditional, protracted testing methodologies

Stay up-to-date on test availability and our latest research and development efforts.

Subscribe to IQuity Insights

Leadership

Dr. Chase Spurlock

Chief Executive Officer

Julia Polk

Chief Strategy Officer/Chief Financial Officer

Dr. Thomas M. Aune

Co-Founder

Kathy Gill

Vice President, Sales & Marketing

Drew Harmata, PhD

Director of Operations

Scientific Advisors

Subramaniam Sriram, M.D.

Professor of Neurology and Director of the Multiple Sclerosis clinic at Vanderbilt

Leslie J. Crofford, M.D.

Director Division of Rheumatology & Immunology at Vanderbilt University Medical Center

Nancy J. Olsen, M.D.

Chief of Rheumatology, Professor of Medicine at Penn State M.S. Hershey Medical Center